politico

Exclusive
‘Bereft’: How Operation Warp Speed’s decisions left the world waiting for a vaccine
In a series of meetings in the fall of 2020, Trump administration officials convened to decide whether a pharmaceutical company they had helped fund and support would be able to deliver what it had promised — Covid-19 vaccine doses for the U.S. and the world.

More than 500,000 people worldwide had died from the virus and the administration was under increasing pressure to find a suitable source of inoculation — and quickly. But one of its top vaccine candidates, Maryland-based Novavax, was reporting data that indicated the company was struggling to find a way to consistently manufacture a high-quality shot. And it did not yet have tests that could determine the levels of purity within each tranche.

“It was a total mess,” one person with direct knowledge of Novavax’s production process said of the situation, expressing a view that at least two other people who attended the meetings shared. This account is based on the recollections of those people, along with five current and former senior officials, four of whom requested anonymity to disclose internal deliberations.
دیدگاه ها (۱)

Philosophy is not a subject — it is the way we wake up to ou...

Why do you think people listen to music?Isn't it to find a l...

The day you said you were leaving, you said it so casually, ...

The clock hands were locked on the last moment of your prese...

#يافاطمة_أغيثيني #يآزهرآء #يازهراء #يامولاتي #يافاطمة In the...

The world is full of holes of regret.. regrets at the right ...

You know, I've come to realize something. I was just like ev...

MAKES IT SO ⬇️Lyrics⬇️ Oh, oh, here we go It's all in the wa...

Syed Ali Hussaini Khamenai, those words feel too small. His ...

I suppose the world eventually brings everyone to the same p...

در حال بارگزاری

خطا در دریافت مطلب های مرتبط